Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

NCT00067561 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

702

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Colon
Irritable Bowel Syndrome (IBS)

Interventions

DRUG: Alosetron

Sponsor

GlaxoSmithKline